lll 
a 
< 
e 
ft. 
< 
e 
ft. 
a 
<§• 
III! 
°s‘l 
ll! 
0 6| 
< 
1 
a. 
p/FDA 
ud NIH 
3 
a 
a 
h 
a 
e 
h 
£ 
'L. 
- 
£ 
o 
£ 
2 
2 
2 
2 
IS 
o 
o 
II 
£ 
1 
ft. 
2 
2 
2 
2 
2 
g^i'cl 
A ii c .S a 
3 V .9 “ -g 
>. -D .5 
c A C3 
A .« r? 6 0 
£ 
Probkms 
with Gcfic 
Transfer 
£ 
£ 
ft. 
2 
2 
2 
2 
2 
O 
Z 
£ 
£ 
■li 
Q ^ 
£ 
£ 
2 
2 
2 
2 
2 
2 
tl 
>■ 
£ 
In Vivo Evidence o( 
Gene Transfer 
e 
z « 
1 
£ 
£ 
ft. 
2 
2 
2 
ft. 
2 
2 
2 
2 
:> 
ft. 
o 
3 
>■ 
ft. 
fri 
Paiienu 
Enlerod on(o 
Study 
o 
o 
<s 
o 
o 
o 
o 
o 
<^ 
r* 
^1 i 
3 II 
2 a- < 
r«4 
<*4 
C4 
o 
IS 
s 
a 
o 
w 
2 
a 
tic- 
2 j 
a 
0 1 
? & 
><^ 
§ 
6 
6 
U 
S 
U 
g 
U 
12 
g 
2 
§ 
g 
a 
a S 
a ^ 
j£ 
D 
i’S 
5 
O. 
r* 
3 
ft. 
r* 
1 
3 
ft. 
1 
r» 
2 
Ih 
o ^ 
2 
r** 
2 
S 
s 
0 
1 
e> 
>=„ 8 
|£ 
i 5 
>: cd 
8 8 
5.15. 
1 -z 
5 5 
< ai 
8 S 
1 = 1 
3 “ z 
5 5 
< 
i 
5 
at: 
8 
c 
d Id 
8 8 
|“5 
3 O 
•g 
ill 
d (d 
8 8 
§8^ 
f -5 
3 5 
5 
i 
3 
n ^ 
Date First 
Patient Treated 
S! 
ft. 
ft. 
A 
4 
2 
2 
ft. 
ft. 
ft. 
1 
6~ 
s 
A 
4 
s 
di 
a 
c 
S 2 
? <3 
«• Q 
e 
Z <0 
ca 
:? 
a 
16 
Z 
z 
m 
e 
2 ; .5 
X c 
|i 
ii 
OQ 
z-^ 
£ z 
1| 
2 i- 
z 1 
m ~J 
z a 
S| 
1 .8 
1 5 
2 ^ 
CQ ”• 
1 i 
£ 8^ 
■8 1E 
|3 
w 
<32 
is 
CQ 
i 
<3 
b 
b 
z 
z 
z 
z 
z 
z 
z 
z 
H 
z 
H 
H 
H 
X 6 Ji 
2 |Q 
S 
4 
li 
S 
4 
ob 
s 
s 
IS 
Si 
? 
A 
1 
2 
s 
4. 
IS 
S 
4. 
A 
c 
4 
4 
s 
o& 
U ^ W 
< 
s 
3 
K 
3 
s 
4 
5 
e 
4 
£! 
4 
5 
s; 
4 
? 
5 
2 
* ? 
i i 
i 
d. 
§ 
d. 
S 
A 
s 
A 
i 2 
C| 
■2 5 
2 
li 
* 
s S 
|£ 
P 
S u 
l§ 
-1 
ll 
§ 
ll 
|c5 
“1 
^ £ 
lip 
& 
1 = 
1 
1 
1 
1 
1 
1 
1 
II 
1 
I 
m 
« 
1 
